Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mercedes Robles-Diaz

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 31, 2016
Characterizing Drug-Induced Liver Injury With Autoimmune FeaturesRaúl J Andrade, Mercedes Robles-Diaz, Agustín Castiella
Alimentary Pharmacology & Therapeutics|July 31, 2019
Reply letter to "Editorial: bodybuilders beware"Mercedes Robles-Diaz, Inmaculada Medina-Cáliz, Raúl J Andrade, et al.
Gastroenterology|December 3, 2014
Reply: To PMID 24704526Mercedes Robles-Diaz, Neil Kaplowitz, Camilla Stephens, et al.
Gastroenterology|December 24, 2014
Reply: To PMID 24704526Mercedes Robles-Diaz, Neil Kaplowitz, Camilla Stephens, et al.
Seminars in Liver Disease|May 4, 2019
Assessment of Serious Acute and Chronic Idiosyncratic Drug-Induced Liver Injury in Clinical PracticeFernando Bessone, Mercedes Robles-Diaz, Nelia Hernandez, et al.
Archives of Toxicology|August 28, 2020
Drug induced liver injury: an updateMiren Garcia-Cortes, Mercedes Robles-Diaz, Camilla Stephens, et al.
Alimentary Pharmacology & Therapeutics|December 22, 2022
Potential benefit and lack of serious risk from corticosteroids in drug-induced liver injury: An international, multicentre, propensity score-matched analysisHao Niu, Jiayi Ma, Inmaculada Medina-Caliz, et al.
Pharmacological Research|December 28, 2020
Prevention and management of idiosyncratic drug-induced liver injury: Systematic review and meta-analysis of randomised clinical trialsHao Niu, Judith Sanabria-Cabrera, Ismael Alvarez-Alvarez, et al.
Plos One|April 16, 2014
Selected ABCB1, ABCB4 and ABCC2 polymorphisms do not enhance the risk of drug-induced hepatotoxicity in a Spanish cohortEugenia Ulzurrun, Camilla Stephens, Francisco Ruiz-Cabello, et al.
Plos One|October 17, 2015
Correction: Selected ABCB1, ABCB4 and ABCC2 Polymorphisms Do Not Enhance the Risk of Drug-Induced Hepatotoxicity in a Spanish CohortEugenia Ulzurrun, Camilla Stephens, Francisco Ruiz-Cabello, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 31, 2016
Characterizing Drug-Induced Liver Injury With Autoimmune FeaturesRaúl J Andrade, Mercedes Robles-Diaz, Agustín Castiella
Alimentary Pharmacology & Therapeutics|July 31, 2019
Reply letter to "Editorial: bodybuilders beware"Mercedes Robles-Diaz, Inmaculada Medina-Cáliz, Raúl J Andrade, et al.
Gastroenterology|December 3, 2014
Reply: To PMID 24704526Mercedes Robles-Diaz, Neil Kaplowitz, Camilla Stephens, et al.
Gastroenterology|December 24, 2014
Reply: To PMID 24704526Mercedes Robles-Diaz, Neil Kaplowitz, Camilla Stephens, et al.
Seminars in Liver Disease|May 4, 2019
Assessment of Serious Acute and Chronic Idiosyncratic Drug-Induced Liver Injury in Clinical PracticeFernando Bessone, Mercedes Robles-Diaz, Nelia Hernandez, et al.
Archives of Toxicology|August 28, 2020
Drug induced liver injury: an updateMiren Garcia-Cortes, Mercedes Robles-Diaz, Camilla Stephens, et al.
Alimentary Pharmacology & Therapeutics|December 22, 2022
Potential benefit and lack of serious risk from corticosteroids in drug-induced liver injury: An international, multicentre, propensity score-matched analysisHao Niu, Jiayi Ma, Inmaculada Medina-Caliz, et al.
Pharmacological Research|December 28, 2020
Prevention and management of idiosyncratic drug-induced liver injury: Systematic review and meta-analysis of randomised clinical trialsHao Niu, Judith Sanabria-Cabrera, Ismael Alvarez-Alvarez, et al.
Plos One|April 16, 2014
Selected ABCB1, ABCB4 and ABCC2 polymorphisms do not enhance the risk of drug-induced hepatotoxicity in a Spanish cohortEugenia Ulzurrun, Camilla Stephens, Francisco Ruiz-Cabello, et al.
Plos One|October 17, 2015
Correction: Selected ABCB1, ABCB4 and ABCC2 Polymorphisms Do Not Enhance the Risk of Drug-Induced Hepatotoxicity in a Spanish CohortEugenia Ulzurrun, Camilla Stephens, Francisco Ruiz-Cabello, et al.
Pageof 3